Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Our solutions enable a spectrum of genomic analysis, from low-cost genotyping arrays and small sequencing panels, all the way up to whole genome sequencing.
In clinical and research settings our technology is not only utilized in oncology, genetic and rare diseases, reproductive health and infectious diseases but also in pharmacogenomics, genetic disease testing and polygenetic risk scores. Our systems are enabling scientific advances that were not even imaginable just a few years ago. A good example is linked to the current pandemic and the use of sequencing in COVID-19.
Using the power of genomics, we are coming closer to the realization of personalized medicine and everything we do is aimed at providing patients with faster and more accurate diagnosis.
We have more than 7800 employees globally. Of this more than 100 employees are working in the Netherlands in various roles such as customer service, logistics, analytics, application support, sales or marketing.
More information about Illumina can be found on our website.